Are Dietary Cholesterol Intake and Serum Cholesterol Levels Related to Nonalcoholic Fatty Liver Disease in Obese Children? by Dimitrios Papandreou et al.
Hindawi Publishing Corporation
Cholesterol
Volume 2012, Article ID 572820, 5 pages
doi:10.1155/2012/572820
Research Article
Are Dietary CholesterolIntake and Serum
CholesterolLevelsRelatedtoNonalcoholic
Fatty Liver Disease in ObeseChildren?
DimitriosPapandreou,1,2 ZaharoulaKarabouta,1 andIsraelRousso1
12nd Department of Pediatrics, School of Medicine and Ahepa General Hospital, Aristotle University of Thessaloniki,
Street Kiriakidi 1, 54636 Thessaloniki, Greece
2Department of Life and Health Sciences, University of Nicosia, Makedonitissas Avenue, 1700 Nicosia, Cyprus
Correspondence should be addressed to Dimitrios Papandreou, papandreoudimitrios@yahoo.gr
Received 5 April 2012; Accepted 16 May 2012
Academic Editor: Roya Kelishadi
Copyright © 2012 Dimitrios Papandreou et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Nonalcoholic fatty liver disease (NAFLD) in children has been recognized as a major health burden. Serum lipids
as well as dietary cholesterol (DC) intake may positively relate to development of NAFLD. The purpose of this study was
to investigate anthropometric, biochemical, and dietary intake parameters of obese Greek children with and without NAFLD.
Materials and Methods. Eighty-ﬁve obese children aged 8–15 (45 boys/40 girls) participated in the study. NAFLD was diagnosed
by ultrasonography (US) in all subjects. Liver indexes were measured in all children. A 3-day dietary was recorded for all subjects.
Results. 38 out of 85 children (44.7%) were found to have fatty liver. Obese children with increased levels of TC (95% CI: 1.721–
3.191), low density lipoprotein (LDL) (95% CI: 1.829–3.058), and increased dietary cholesterol intakes (95% CI: 1.511–2.719)
were 2.541, 2.612, and 2.041 times more likely to develop NAFLD compared with the children without NAFLD. Conclusion.T h e
present study showed that TC, LDL, and DC were the strongest risk factors of development of NAFLD. Reducing body weight and
dietary cholesterol intakes as well as decreasing serum TC and LDL levels are urgently necessary in order to prevent NAFLD and
possible other health implications later in life.
1.Introduction
Nonalcoholic fatty liver disease (NAFLD), which encom-
passes a broad spectrum of liver disorders ranging from sim-
ple hepatic steatosis to steatohepatitis (NASH) and cirrhosis,
is currently the most common cause of chronic liver disease
and abnormal liver function tests in Western countries [1].
The development of hepatic steatosis is considered to be
associated with an excess intake of calories, visceral obesity,
and insulin resistance, which result in an increased release
of free fatty acids from adipocytes and increased rates of
fatty acid synthesis in the liver [1]. Therefore, nutritional
management and therapeutic exercise are fundamental steps
to treat NAFLD.
The “two-hit theory” is increasingly being adopted to
explain the pathogenesis of NAFLD and NASH [2]. In
this theory, the ﬁrst hit consists of the accumulation of
fatty acids/triglycerides in the liver, while the second hit
involves oxidative stress, mitochondrial dysfunction, and
inﬂammation, which ultimately cause liver damage.
Hepatic lipid homeostasis represents a balance between
lipid uptake, synthesis, catabolism, and secretion. Therefore,
steatosis, a typical characteristic of NAFLD, is expected to be
caused by disordered lipid metabolism, particularly inhibi-
tion of fatty acid oxidation and enhanced lipogenesis. Many
factors involved in hepatic lipid metabolism pathways have
been identiﬁed, even though the precise cellular networks
are not fully elucidated. In humans with NAFLD, cholesterol
uptake in the form of LDL is limited by the intracellular
accumulation of fatty acid and cholesterol, while fatty acid
and cholesterol synthesis are upregulated in the NAFLD liver
suggesting that the feedback system regulating and clearing
up intracellular lipids levels is disrupted in NAFLD [3].2 Cholesterol
The prevalence of NAFLD in children remains unknown
because of the lack of population-based studies and reliable
screening tools. The available data suggests a prevalence
range from 2.6% to 9.6% among children and adolescents
in the United States and Asia which may reach to 12–80%
in overweight and obese children [4]. Even though there is
no consensus for the treatment for NAFLD in children, a
recent review shoed that many studies have been attempted
to treat NAFLD using weight loss and exercise, antioxidants,
and pharmacological agents [5].
Some studies have been suggesting that high-fat, high-
fat plus low-protein, high-carbohydrate, and/or high-
cholesterol diets are the main causes of NAFLD [6–8]. The
reason for this is that cholesterol overload can upregulate
geneexpressionandactivatefattyacidsynthesisbyincreasing
oxysterollevels,metabolitesofcholesterolthatactasagonists
for these genes indicating that excess cholesterol intake (i.e.,
cholesterol supply) itself can be a strong stimulant for the
development of steatosis [9].
The purpose of this study was to investigate possible
diﬀerences of certain parameters such as anthropometric,
biochemical, and dietary of obese Greek children with and
without NAFLD.
2.MaterialsandMethods
Eighty-ﬁve (85) obese children aged 8–15y (45 boys/40
girls) were initially referred for obesity assessment to the
outpatient 2nd Pediatric Department of Aristotle University
of Thessaloniki, between January 2007 and January 2011. All
children were screened for parameters of NAFLD. Written,
informedconsentwasalsoobtainedfromeachchild’sparents
who participated in the study.
2.1. Anthropometrics and Biochemical Indexes. Anthropo-
metrical indices such as height, weight, Tanner stage, and
waist circumference were assessed in all children. Obesity
was deﬁned by International Obesity Task Force criteria
for age and sex [10]. BMI was calculated by dividing
weight (kg) by height squared (m2). Biochemical indices
such as liver transaminases (ALT, AST), lipid proﬁle, total
cholesterol(TC),lowdensitylipoprotein(LDL),highdensity
lipoprotein (HDL), and triglycerides (TG) were measured
in all children. All children had normal serum levels
of alanine aminotransferase (ALT) <40U/L and aspartate
aminotransferase (AST) <37U/L. Participants were free of a
history of clinical evidence of diabetes, cardiovascular, liver
disease,hepatitsBorC,useofalcohol,drugs,orotherdisease
(e.g., Wilson’s disease, autoimmune hepatitis). NAFLD was
diagnosed by ultrasonography (US) and was classiﬁed as
having no or moderate hepatic steatosis (Grade II). The
examination was performed by a radiologist with a convex
probe (3.5–5MHZ) with Elegra-Siemens equipment. The
echogenicity of the liver was estimated in a longitudinal US
slice, showing the liver parenchyma and the neighboring
right kidney [11].
Insulin resistance (IR) was calculated by means of the
homeostasis model assessment (HOMA). IR was deﬁned by
HOMA >3.2μU/mL [12].
2.2. Dietary Intake. A validated dietary intake [13]w a su s e d
to collect information for a total of 3 days (2 weekdays
and 1 weekend day). Study participants together with their
parents were asked to describe the type and amount of
food consumed after a detailed explanation and guidance
provided by a registered dietician of our clinic. To improve
the accuracy of food description, food models were used
to describe the portion sizes. The dietary record was then
analyzed using a software program (Sciencetech Diet 200A,
Science Technologies, Athens, Greece, 2001) which consisted
of more than 2500 Greek food items and recipes.
2.3. Statistical Analysis. Standard descriptive statistics were
used for all patient characteristics. Data for continuous
variables is expressed as mean values ± standard deviation.
t-test was used to compare characteristics of obese children
with and without NAFLD. Partial correlation was estimated
by using Spearman’s correlation coeﬃcient. Logistic regres-
sion analysis was used to estimate the relationship between
ultrasound ﬁndings (normal or pathological) with HOMA,
BMI, WC, HDL, LDL, dietary cholesterol, saturated fatty
acid, sugar, and ﬁber consumed daily. P values < 0.05
were considered statistically signiﬁcant, while all conﬁdence
intervals (C.I.) represent 95% intervals.
3. Results
Based on ultrasonography, 38 out of 85 children (44.7%)
were found to have fatty liver.
Anthropometric and biochemical characteristics of all
subjects were presented in Table 1. Children with NAFLD
were having higher BMI, WC TC, and LDL and lower HDL
levels compared to children without NAFLD. In addition IR
was signiﬁcantly higher in obese children with NAFLD.
The dietary intakes of energy and major nutrients in the
three categories are reported in Table 2. SFA, cholesterol, and
sugar intakes were signiﬁcantly higher in group with NAFLD
compared with the group without NAFLD.
In Spearman’s correlation model, BMI, WC, TC, LDL,
and dietary cholesterol were found to be positively correlated
with NAFLD, while HDL levels were negatively associated
with NAFLD (Table 3).
In logistic regression analysis, obese children with
increased levels of TC (95% CI: 1.721–3.191), low density
lipoprotein (LDL) (95% CI: 1.829–3.058), and increased
dietarycholesterolintakes(95%CI:1.511–2.719)were2.541,
2.612, and 2.041 times more likely to develop NAFLD
compared with the obese children without NAFLD (Table 4).
4. Discussion
In the current study, we presented clinical data of 85 obese
children with and without NAFLD proven by ultrasonog-
raphy and its association with anthropometric and clinicalCholesterol 3
Table 1: Clinical characteristics of subjects based on fatty liver.
Absent
(n=47)
Moderate (Grade II)
(n=38) P value
Sex (M/F) 25/22 20/18 0.451
Age (y) 11 ±2.1 11.5±1.1 0.369
BMI (kg/m2)2 5 ±3.6 31±2.9 0.001
WC (cm) 85.2±11.2 97±10.9 0.001
ALT (U/L) 22.7±6.2 26±4.1 0.942
AST (U/L) 21.1±7.4 25.1±3.2 0.212
TC (mg/dL) 168.7±27.4 179±19.8 0.006
HDL (mg/dL) 50.3±13.1 40±12.1 0.002
LDL (mg/dL) 103.7±22.1 94±9.6 0.043
TG (mg/dL) 110.2±54.3 109.1±60 0.294
CRP 2.2±2.8 2.4±2.6 0.591
HOMA-IR 4.3±1.9 6.2±2.1 0.001
Values are presented as means±SD. Statistical signiﬁcant diﬀerence
(P<0.05). Abbreviations: BMI: body mass index, WC: waist circumference,
ALT: alanine aminotransferase, AST: aspartate aminotransferase, TC: total
cholesterol, LDL: low density lipoprotein, HDL: high density lipoprotein,
TG: triglycerides, CRP: C-reactive protein, HOMA-IR: homeostasis model
assessment of insulin resistance.
Table 2: Dietary intake of subjects based on fatty liver.
Absent
(n=47)
Moderate (Grade II)
(n=38) P value
Energy (kcal) 2444±539 2605±489 0.641
PRO (g) 103.1±27.7 97±23.3 0.323
CHO (g) 244.5±67.5 276.1±51.9 0.051
FAT (g) 139.7±45.1 138±41.9 0.079
SFA (g) 45.1±12.6 61.9±11.8 0.032
CHOL (mg) 321±29.7 378±28.7 0.001
Sugar (g) 10.8±15.3 21±12.9 0.002
Fiber (g) 20.0±8.0 15±9.1 0.081
Values are presented as means±SD. Statistical signiﬁcant diﬀerence
(P<0.05). Abbreviations: PRO: protein, CHO: carbohydrates, SFA: satu-
rated fatty acid, CHOL: dietary cholesterol.
parameters as well as with dietary intakes. The prevalence
of our sample data was 38/85 (44.7%) which is between the
prevalence (12–80%) found by other authors in a review
study of diﬀerent regions of the world such as Europe,
America, and Asia [4].
IthasbeenreportedthatthedegreeofsteatosisinNAFLD
is proportional to the degree of obesity [14]. BMI and WC
were found in our study positively correlated with hepatic
fat content. However, none of them were of the strongest
risk factors of developing NAFLD in the logistic regression
model analysis, suggesting that obesity and splanchnic fat
distribution might also be eﬀects of insulin resistance, rather
than being directly involved in the etiology of fatty liver.
In our study the obese children with NAFLD were
presented to have increased levels of insulin resistance,
dyslipidemia, and WC. NAFLD is strongly associated with
obesity, insulin resistance, hypertension, and dyslipidemia
and is now regarded as the liver manifestation of the
metabolic syndrome (MetS) [15], a highly atherogenic
condition.
Diets rich in fatty acids mainly saturated and trans-
fatty acids, as well as carbohydrate-rich diets, favor an acute
increaseinIRindependentofadiposity[16].HighSFAintake
may also promote steatohepatitis directly by modulating
hepatic triglyceride accumulation and oxidative activity
as well as indirectly by aﬀecting insulin sensitivity and
postprandialtriglyceridemetabolism[17].SFAconsumption
where found to be signiﬁcantly higher in children with
NAFLD compared with the children without NAFLD.
The consumption of sugar has been linked to risks
for obesity, diabetes, metabolic syndrome, fatty liver, and
heart disease, possibly by providing excess calories and large
amounts of rapidly absorbable sugars [18, 19]. Our results
showed that obese children with NAFLD had signiﬁcantly
higher intakes compared to children without NAFLD.
The most important ﬁnding of our study was that the
childrenwithNAFLDconsumedsigniﬁcantlyhigherlevelsof
dietary cholesterol compared to children without NAFLD. In
addition, the total serum cholesterol levels of the same group
were also found to signiﬁcantly higher, compared with the
group without NAFLD.
Observational studies have been conﬂicting with regard
to our ﬁndings. Some studies did not demonstrate diﬀerent
dietary intakes of cholesterol between NAFLD patients and
controls[20,21].However,Mussoetal.[17]diddemonstrate
a higher cholesterol consumption among normal weight
NASH patients versus BMI matched controls. A recent study
supported the role of dietary cholesterol in NAFLD. In this
study, 12 normal weight NAFLD patients were compared
to 44 obese NAFLD patients. A characteristic feature was
that dietary cholesterol intake was signiﬁcantly higher, while
the intake of polyunsaturated fatty acids (PUFAs) was sig-
niﬁcantly lower, in the nonobese group. Similar diﬀerences
were noted in comparison to 15 healthy nonobese controls.
Therefore, this altered cholesterol and PUFA intake may be
associated with the development of NAFLD in nonobese
patients [9]. In addition, studies using nonobese animal
models have conﬁrmed that a diet high in cholesterol can
induce NASH [22].
Obese children with NAFLD should be informed that
a healthy diet has beneﬁts beyond weight reduction. They
should be advised to reduce saturated/trans-fat and increase
polyunsaturated fat with special emphasize on omega-3 fatty
acids. They should reduce added sugar to its minimum, and
increase ﬁber intake. Physical activity should be integrated
into behavioral therapy in NAFLD, as even small gains
in PA and ﬁtness may have signiﬁcant health beneﬁts. A
combination of educational, behavioral, and motivational
strategies is required to help patients achieve lifestyle change.
5. Conclusion
The present study showed that TC, LDL, and DC were the
strongest risk factors of development of NAFLD. Reducing
body weight and dietary cholesterol intakes as well as4 Cholesterol
Table 3: Parameters associating with NAFLD by Spearman’s
correlation coeﬃcient.
Parameters rP value
BMI (kg/m2) 0.521 0.001
WC (cm) 0.296 0.001
HOMA-IR 0.175 0.501
TC (mg/dL) 0.533 0.001
HDL (mg/dL) −0.281 0.031
LDL (mg/dL) 0.419 0.021
SFA (g) 0.081 0.092
CHOL (mg) 0.312 0.009
Sugar (g) 0.109 0.290
Statistical signiﬁcant diﬀerence (P<0.05). Abbreviations: BMI: body mass
index, WC: waist circumference, HDL: high density lipoprotein, HOMA-IR,
homeostasis model assessment of insulin resistance, TC: total cholesterol,
SFA: saturated fatty acids, CHOL: dietary cholesterol.
Table 4: Parameters associating with NAFLD by logistic regression
analysis∗.
Parameters Odds Ratio 95% CI P value
BMI (kg/m2) 1.141 (0.871–1.645) 0.349
WC (cm) 1.192 (0.941–1.779) 0.452
HOMA-IR 1.488 (1.108–1.877) 0.229
TC (mg/dL) 2.541 (1.721–3.191) 0.001
HDL (mg/dL) 1.228 (0.877–1.524) 0.612
LDL (mg/dL) 2.612 (1.829–3.058) 0.001
SFA (g) 1.211 (0.544–1.612) 0.053
CHOL (mg) 2.041 (1.511–2.719) 0.009
Sugar (g) 0.448 (0.156–0.997) 0.319
Statistical signiﬁcant diﬀerence (P<0.05). ∗Adjusted for age, gender,
and energy intake. Abbreviations: BMI: body mass index, WC: waist
circumference, HDL: high density lipoprotein, HOMA-IR: homeostasis
model assessment of insulin resistance, CHOL: dietary cholesterol, SFA:
saturated fatty acids.
decreasing serum TC and LDL levels is urgently necessary
in order to prevent NAFLD and possible other health
implications later in life.
6. Limitations
Limitations of our study include the small size of the
participants and the lack of liver biopsy. We also did not
present activity level of patients as well as socioeconomic
data.
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